References
- Hryniuk W M. The importance of dose intensity in the outcome of chemotherapy. Important Advances in Oncology, V T DeVita, S Hellman, S A Rosenberg, 1988; 121–42
- DeVita V T. Principles of chemotherapy. Cancer principles and practice of oncology, V T DeVita, S Hellman, S A Rosenberg. J.B. Lippincott Co., Philadelphia 1987, chapter 16
- Gale R P. Antineoplastic chemotherapy myelosuppression: Mechanisms and new approaches. Exp Hematol 1985; 3–7, Suppl. 13
- Pannacciulli J, Massa G, Bagliali G, Sabrero A. Effect of high-dose methotrexate and leukonovin on murine hematopoietic stem cells. Cancer Res 1982; 42: 530–4
- Ditel D. What's new in cytostatic drug resistance and pathology. Pathol Res Pract 1991; 187: 892–905
- Stebbing N. Biotherapeutic agents obtained by recombinant DNA methods. Principles of cancer biotherapy, R K Oldham. Raven Press, Ltd., New York 1987; 65–91
- Scheper R J, Limpens J, Tan B TG, Valster H, Claessen M E. Immunotherapeutic effects of local chemotherapy with an active metabolite of cyclophosphamide. Methods Find Exp Clin Pharmocol 1987; 9: 611–5
- Hengst J CD, Kempf R A. Immunomodulation by cyclophosphamide. Clinics in Immunology and Allergy 1984; 4: 199–216
- Hagenbeek A, Martens A CM. Normal tissue protection by a small priming dose of cyclophosphamide prior to high-dose chemotherapy in the BN acute myelocytic leukemia. Ann Rep Radiobiol Inst TNO, Rijswijk 1981; 195–202
- Botik J E, Honnon E G, Vignelle R, Hellman S. Differential effects of cytotoxic agents on hematopoietic progenitors. Cancer Res 1981; 41: 2338–42
- Fraiser L H, Kanekal S, Kehrer J P. Cyclophosphamide toxicity, characterizing and avoiding the problem. Drugs 1991; 42: 781–95
- Grant L D, Keasberg P R, Ershler B E. Immunologic effects of cancer chemotherapy. The toxiity of anticancer drugs, G Powis, M P Hacker. Pergamon Press. 1991; 167–97
- Karp J E, Burke P J. Influence of humoral regulators proliferation and maturation on normal and leukemic cells. Cancer Res 1976; 36: 1674–9
- Puji N, Petrovi N, Kolašinovi N. The effect of the rat cyclophosphamide serum on the rat hematopoietic tissue recovery, previously damaged by cyclophosphamide or by gamma-irradiation. Stralenther Oncol 1987; 63: 50–3
- Ozer H. Effects of alkylating agents on immunoregulatory mechanisms. Biological responses in cancer, E Mihich, Y Sakuri. Plenum Press, New York 1985; Vol. 13: 95–130
- Yoshida S, Nomoto K, Himeno K, Umezawa H. Immune response to syngeneic or autologous testicular cells in muce. I. Augmented delayed footpad reaction in cyclophosphamide-treated mice. Clin Exp Immunol 1979; 38: 211–7
- Young M RI, Wright M A, Young M E, Bagash J. Tumor-derived cytokines induce bone marrow suppressor cells that mediate immunosuppression through transforming growth factor-beta. Cancer Immunol Immunother 1992; 35: 14–8
- Berd D, Magueire H C, Mastrangelo M J. Potentiation of human cell-mediated and humoral immunity by low dose cyclophosphamide. Cancer Res 1984; 44: 5439–43
- Sharma B, Vaziri N D. Augmentation of human natural killer cell activity by cyclophosphamide in vitro. Cancer Res 1984; 44: 3258–61